Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China, U.S. Agree On Ensuring Defective Drugs Not Sent to U.S. (China)

This article was originally published in PharmAsia News

Executive Summary

U.S. and Chinese drug authorities reached an agreement at a summit meeting on safety issues designed to ensure China will not export defective food or drugs to the United States. The drug and medical equipment agreement also requires U.S. authorities to notify Chinese counterparts of recalls, warning letters and reports on adverse side effects. The two sides also agreed to joint investigations by their respective FDAs of suspected companies when defective products are discovered. Implementation details are to be worked out over the next four months. (Click here for more ) "Pact On Drugs, Equipment Safety Inked" China Daily (12/13/07)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts